Celsius Therapeutics, Inc. — Form D/A
Celsius Therapeutics, Inc. of CAMBRIDGE, MA, a company, filed a Form D amendment with the SEC on 2019-10-04. The offering totals $65.0M, of which $48.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2019-10-04
- Form: D/A
- Accession: 0001744560-19-000001
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $65.0M
- Amount sold: $48.0M
- Remaining: $17.0M
- Investors: 6
- Date of first sale: 2018-05-14
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-315973
Issuer
- Name: Celsius Therapeutics, Inc.
- CIK: 0001744560
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2017
- Address: 399 Binney Street, CAMBRIDGE, MA, 02139
- Phone: (857) 776-7400
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Tariq Kassum | Director | Cambridge, MA |
| Christoph Lengauer | Director | Cambridge, MA |
| Michael Boretti | Executive Officer | Cambridge, MA |
| Tariq Kassum | Executive Officer | Cambridge, MA |
| Christoph Lengauer | Executive Officer | Cambridge, MA |
| Alexis Borisy | Director | Boston, MA |
| Alexis Borisy | Executive Officer | Boston, MA |
| Colleen DeSimone | Executive Officer | Cambridge, MA |
Other filings by this issuer (1)
More